---
figid: PMC7266824__OTT-13-4877-g0002
figlink: pmc/articles/PMC7266824/figure/F0002/
number: Figure 2
caption: 'Mechanisms of ibrutinib resistance in CLL and mutations in pathways governing
  BCR signaling.Notes: (A) The BTK mutation attenuated its binding to ibrutinib, resulting
  in a reduced ability to inhibit the phosphorylation of downstream molecules, thereby
  allowing the BCR signal to continue to be passed down. (B) LYN and SYK kinase bypassed
  BTK to directly activate the mutant PLCG2, which caused increased Ca2+ influx to
  activate different oncogenic pathways, including PIK3–Akt, NF-κB survival signaling,
  and the MAP kinase pathway. (C) The binding of IL-4 and IL-6 released from the microenvironment
  to their corresponding receptors activated JAK kinase, followed by the phosphorylation
  of the STAT6 or STAT3. The activated STAT upregulated the expression levels of anti-apoptotic
  proteins MCL-1 and BCL-xL. (D) The acquired short arm of chromosome 2 (2p+) induced
  the overexpression of XPO1. XPO1 promoted the export of tumor suppressor proteins
  (such as p53 and FOXO) to the cytoplasm, thereby relieving their inhibitory effect
  on the cell cycle. (E) Activation of the JAK/STAT signaling pathways might lead
  to overexpression of PD-L1/PD-L2 in patients with RT.Abbreviations: IL-4, interleukin
  4; JAK, Janus kinase; STAT6, signal transducer and activator of transcription factor
  6; MCL-1, myeloid cell leukemia-1; BCL-xL, B-cell lymphoma-xL; XPO1, exportin-1.'
pmcid: PMC7266824
papertitle: 'Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug
  Resistance, and Prospects.'
reftext: Hong Zhou, et al. Onco Targets Ther. 2020;13:4877-4892.
pmc_ranked_result_index: '34807'
pathway_score: 0.9770583
filename: OTT-13-4877-g0002.jpg
figtitle: 'Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug
  Resistance, and Prospects'
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7266824__OTT-13-4877-g0002.html
  '@type': Dataset
  description: 'Mechanisms of ibrutinib resistance in CLL and mutations in pathways
    governing BCR signaling.Notes: (A) The BTK mutation attenuated its binding to
    ibrutinib, resulting in a reduced ability to inhibit the phosphorylation of downstream
    molecules, thereby allowing the BCR signal to continue to be passed down. (B)
    LYN and SYK kinase bypassed BTK to directly activate the mutant PLCG2, which caused
    increased Ca2+ influx to activate different oncogenic pathways, including PIK3–Akt,
    NF-κB survival signaling, and the MAP kinase pathway. (C) The binding of IL-4
    and IL-6 released from the microenvironment to their corresponding receptors activated
    JAK kinase, followed by the phosphorylation of the STAT6 or STAT3. The activated
    STAT upregulated the expression levels of anti-apoptotic proteins MCL-1 and BCL-xL.
    (D) The acquired short arm of chromosome 2 (2p+) induced the overexpression of
    XPO1. XPO1 promoted the export of tumor suppressor proteins (such as p53 and FOXO)
    to the cytoplasm, thereby relieving their inhibitory effect on the cell cycle.
    (E) Activation of the JAK/STAT signaling pathways might lead to overexpression
    of PD-L1/PD-L2 in patients with RT.Abbreviations: IL-4, interleukin 4; JAK, Janus
    kinase; STAT6, signal transducer and activator of transcription factor 6; MCL-1,
    myeloid cell leukemia-1; BCL-xL, B-cell lymphoma-xL; XPO1, exportin-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6R
  - IL4R
  - CD274
  - BCR
  - LYN
  - SYK
  - JAK2
  - JAK1
  - BTK
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PRKCB
  - PLCG2
  - PLP2
  - STAT6
  - STAT3
  - BCL10
  - ARAF
  - BRAF
  - RAF1
  - MALT1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - IKBKG
  - IKBKB
  - MCL1
  - MTOR
  - MAPK3
  - MAPK1
  - NFKBIA
  - RELA
  - XPO1
  - FOXO6
  - FOXO1
  - FOXO3
  - FOXO4
  - Ca2+
  - D993H P664S
genes:
- word: IL6-R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: IL4-R
  symbol: IL4R
  source: hgnc_symbol
  hgnc_symbol: IL4R
  entrez: '3566'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: JAK1/2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK1/2
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKCB
  symbol: PKCB
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PLCG2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MALT1
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: IKBKG
  symbol: IKBKG
  source: hgnc_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKBKB
  symbol: IKBKB
  source: hgnc_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: MCL-1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NFKBIA
  symbol: NFKBIA
  source: hgnc_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: RELA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: ХРО1
  symbol: XPO1
  source: hgnc_symbol
  hgnc_symbol: XPO1
  entrez: '7514'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
chemicals:
- word: Ca2+
  source: MESH
  identifier: D002118
- word: D993H P664S
  source: MESH
  identifier: C028032
diseases: []
---
